The Planning and Evaluation Core (PEC) serves as a facilitative resource to provide oversight and data support in the development, implementation, coordination, and management of all Partnership activities for the Partnership's Infection-Driven Malignancies Program for Advancing Careers and Translational Sciences (IMPACT). This core, which works collaboratively with the Administrative, and DATAOmics Cores, provides assistance with the daily activities of the Partnership, including, but not limited to, data collection, data evaluation, and meeting planning, as well as to spearhead short-term and long-term strategic planning and prioritization for the successful achievement of Partnership initiatives. The PEC is composed of an Evaluation Team (ET), the Internal Advisory Committee (IAC) and the Program Steering Committee (PSC). Through these three components, the PEC conducts via a continuous process, the planning and evaluation of all partnership activities.
Specific Aims for the PEC include: 1) Provide continuous support to cores and research projects to incorporate evaluation tools and approaches in order to document Partnership's progress and accomplishments; 2) Promote an evaluation culture supported through a rigorous internal reviewing process in order to continuously improve Partnership performance and maximize resources; and 3) Support a critical external assessment process of the Partnership in order to enhance its performance, provide recommendations for improvements and inform new directions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA096297-17
Application #
10021570
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-08-16
Project End
2024-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Puerto Rico Med Sciences
Department
Type
DUNS #
948108063
City
San Juan
State
PR
Country
United States
Zip Code
00936
Juan-Rivera, Maylein C; Martínez-Ferrer, Magaly (2018) Integrin Inhibitors in Prostate Cancer. Cancers (Basel) 10:
Cruz-Correa, Marcia; Hylind, Linda M; Marrero, Jessica Hernandez et al. (2018) Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology 155:668-673
Gonzalez-Mercado, Velda J; Fridley, Brooke L; Saligan, Leorey N (2018) Sestrin family of genes and their role in cancer-related fatigue. Support Care Cancer 26:2071-2074
Villar-Prados, Alejandro; Wu, Sherry Y; Court, Karem A et al. (2018) Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein BRD4. Mol Cancer Ther :
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Marqués-Lespier, Juan M; Soto-Salgado, Marievelisse; González-Pons, María et al. (2018) Prevalence of Synchronous Oligopolyposis in Incident Colorectal Cancer: A Population-Based Study. P R Health Sci J 37:39-45
Maldonado, María Del Mar; Dharmawardhane, Suranganie (2018) Targeting Rac and Cdc42 GTPases in Cancer. Cancer Res 78:3101-3111
González-Pons, María; Soto-Salgado, Marievelisse; Sevilla, Javier et al. (2018) Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population-based study. Helicobacter 23:
Monroig-Bosque, Paloma Del C; Shah, Maitri Y; Fu, Xiao et al. (2018) OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep 8:13106
Das, Soma; Parga, Kenia; Chakraborty, Indranil et al. (2018) Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents. J Inorg Biochem 186:176-186

Showing the most recent 10 out of 157 publications